Sex and Gender Identification and Implications for Disability Evaluation
Seiten
2025
National Academies Press (Verlag)
978-0-309-71931-5 (ISBN)
National Academies Press (Verlag)
978-0-309-71931-5 (ISBN)
- Noch nicht erschienen (ca. Juni 2025)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Transgender and gender diverse (TGD) people and people with variations in sex traits (VSTs) can experience serious health challenges and often have a greater burden of disability or greater morbidity from chronic disease compared with the general population.
"Transgender and gender diverse" refers to people whose gender identity differs from what is typically associated with their sex recorded at birth. "Variations in sex traits" refers to genetic, anatomical, and hormonal variations that affect the genitourinary tract and reproduction systems; individuals with VSTs may have a sex and/or gender identity that differs from their sex recorded at birth.
The U.S. Social Security Administration (SSA) asked the National Academies to convene a committee of experts to evaluate how contemporary conceptions of sex and gender in medicine and current clinical guidelines impact disability determinations. The resulting report offers conclusions in key areas including (1) the collection of data on sex and gender identity, (2) disability considerations for SSA' Listings of Impairments (medical criteria that apply to the evaluation of disability) with sex-specific diagnostic criteria, (3) inclusive language in disability Listings of Impairments, and (4) guidance for adjudicators on assessing disability for TGD applicants and applicants with VSTs.
Table of Contents
Front Matter
Summary
1 Introduction
Part I: Sex and Gender Data Collection and Clinical Practice
2 Clinical Conceptions of Sex and Gender
3 Data on Sexual Orientation and Gender Identity: Collection and Use in the Clinical Practice of Medicine
4 Data on Sex and Gender Identity: Collection across the U.S. Health Care System
Part II: Affirming Treatment and Care for Transgender and Gender Diverse People and People with Variations in Sex Traits
5 Gender-Affirming Care for Transgender and Gender Diverse People
6 Common Co-Occurring Conditions and Impacts of Gender-Affirming Care on Chronic Conditions in Transgender and Gender Diverse Populations
7 Care for Individuals with Variations in Sex Traits
Part III: Sex, Gender, and Disability Determinations Introduction
8 Chronic Respiratory Disorders
9 Childhood Growth Failure
10 Chronic Kidney Disease
11 Cancers of the Reproductive System
12 Considerations for HIV Manifestations Specific to Women
13 Considerations for Disability Adjudication for Transgender and Gender Diverse Applicants and Applicants with Variations in Sex Traits
14 Overall Conclusions
Appendix A Public Meeting Agendas
Appendix B Committee Member Biosketches
Appendix C Commissioned Paper Physiological Sex Differences and the Effect of Gender-Affirming Hormone Therapy
"Transgender and gender diverse" refers to people whose gender identity differs from what is typically associated with their sex recorded at birth. "Variations in sex traits" refers to genetic, anatomical, and hormonal variations that affect the genitourinary tract and reproduction systems; individuals with VSTs may have a sex and/or gender identity that differs from their sex recorded at birth.
The U.S. Social Security Administration (SSA) asked the National Academies to convene a committee of experts to evaluate how contemporary conceptions of sex and gender in medicine and current clinical guidelines impact disability determinations. The resulting report offers conclusions in key areas including (1) the collection of data on sex and gender identity, (2) disability considerations for SSA' Listings of Impairments (medical criteria that apply to the evaluation of disability) with sex-specific diagnostic criteria, (3) inclusive language in disability Listings of Impairments, and (4) guidance for adjudicators on assessing disability for TGD applicants and applicants with VSTs.
Table of Contents
Front Matter
Summary
1 Introduction
Part I: Sex and Gender Data Collection and Clinical Practice
2 Clinical Conceptions of Sex and Gender
3 Data on Sexual Orientation and Gender Identity: Collection and Use in the Clinical Practice of Medicine
4 Data on Sex and Gender Identity: Collection across the U.S. Health Care System
Part II: Affirming Treatment and Care for Transgender and Gender Diverse People and People with Variations in Sex Traits
5 Gender-Affirming Care for Transgender and Gender Diverse People
6 Common Co-Occurring Conditions and Impacts of Gender-Affirming Care on Chronic Conditions in Transgender and Gender Diverse Populations
7 Care for Individuals with Variations in Sex Traits
Part III: Sex, Gender, and Disability Determinations Introduction
8 Chronic Respiratory Disorders
9 Childhood Growth Failure
10 Chronic Kidney Disease
11 Cancers of the Reproductive System
12 Considerations for HIV Manifestations Specific to Women
13 Considerations for Disability Adjudication for Transgender and Gender Diverse Applicants and Applicants with Variations in Sex Traits
14 Overall Conclusions
Appendix A Public Meeting Agendas
Appendix B Committee Member Biosketches
Appendix C Commissioned Paper Physiological Sex Differences and the Effect of Gender-Affirming Hormone Therapy
| Erscheint lt. Verlag | 16.6.2025 |
|---|---|
| Verlagsort | Washington |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
| ISBN-10 | 0-309-71931-3 / 0309719313 |
| ISBN-13 | 978-0-309-71931-5 / 9780309719315 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Eine Einführung in Struktur und Funktionsweise
Buch | Hardcover (2021)
Hogrefe AG (Verlag)
CHF 49,90
Vielfältige Perspektiven für einen konstruktiven Dialog
Buch | Softcover (2022)
Versus (Verlag)
CHF 35,95
Die neue und andere Arbeitskultur im Gesundheitswesen
Buch | Softcover (2022)
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
CHF 97,90
